Biolase Company Profile (NASDAQ:BIOL)

About Biolase

Biolase logoBIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIOL
  • CUSIP:
Key Metrics:
  • Previous Close: $1.65
  • 50 Day Moving Average: $1.23
  • 200 Day Moving Average: $1.21
  • 52-Week Range: $0.60 - $1.81
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -22.13
  • P/E Growth: -0.59
  • Market Cap: $100.78M
  • Outstanding Shares: 58,257,000
  • Beta: 1.86
Additional Links:
Companies Related to Biolase:

Analyst Ratings

Consensus Ratings for Biolase (NASDAQ:BIOL) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biolase (NASDAQ:BIOL)
No equities research coverage for this company has been tracked by


Earnings History for Biolase (NASDAQ:BIOL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2016Q216($0.03)($0.10)$12.90 million$13.80 millionViewN/AView Earnings Details
5/9/2016Q116($0.03)($0.07)$11.90 million$11.00 millionViewN/AView Earnings Details
3/9/2016Q415($0.09)($0.02)$13.90 million$14.50 millionViewN/AView Earnings Details
11/4/2015Q315($0.08)($0.09)$1.50 million$11.20 millionViewN/AView Earnings Details
8/5/2015Q215($0.06)($0.10)$12.30 million$11.90 millionViewN/AView Earnings Details
3/4/2015Q414($0.04)($0.06)$14.90 million$13.20 millionViewN/AView Earnings Details
11/4/2014Q314($0.09)($0.08)$11.70 million$12.70 millionViewN/AView Earnings Details
8/7/2014Q214($0.08)($0.17)$12.97 million$10.20 millionViewN/AView Earnings Details
5/12/2014Q114($0.05)($0.11)$13.29 million$11.50 millionViewN/AView Earnings Details
3/5/2014Q413($0.04)($0.04)$15.67 million$15.20 millionViewN/AView Earnings Details
11/5/2013Q313($0.05)($0.10)$16.42 million$12.30 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.04)($0.06)$15.69 million$14.20 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.01)($0.06)$14.48 million$14.60 millionViewN/AView Earnings Details
3/6/2013Q4 2012$0.05$18.03 million$19.10 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Biolase (NASDAQ:BIOL)
Current Year EPS Consensus Estimate: $-0.14 EPS
Next Year EPS Consensus Estimate: $-0.08 EPS


Dividend History for Biolase (NASDAQ:BIOL)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Biolase (NASDAQ:BIOL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/18/2016Jack W SchulerMajor ShareholderBuy500$0.80$400.00View SEC Filing  
2/17/2016Jack W SchulerMajor ShareholderBuy4,100$0.80$3,280.00View SEC Filing  
2/12/2016Jack W SchulerMajor ShareholderBuy19,080$0.76$14,500.80View SEC Filing  
2/10/2016Jack W SchulerMajor ShareholderBuy67,213$0.78$52,426.14View SEC Filing  
1/25/2016Jack W SchulerMajor ShareholderBuy1,400$0.80$1,120.00View SEC Filing  
1/22/2016Jack W SchulerMajor ShareholderBuy6,670$0.78$5,202.60View SEC Filing  
1/20/2016Jack W SchulerMajor ShareholderBuy24,200$0.75$18,150.00View SEC Filing  
12/28/2015Jack W SchulerMajor ShareholderBuy18,350$0.79$14,496.50View SEC Filing  
12/24/2015Jack W SchulerMajor ShareholderBuy41,900$0.76$31,844.00View SEC Filing  
12/22/2015Jack W SchulerMajor ShareholderBuy87,200$0.74$64,528.00View SEC Filing  
12/21/2015Jack W SchulerMajor ShareholderBuy127,892$0.73$93,361.16View SEC Filing  
12/17/2015Jack W SchulerMajor ShareholderBuy34,158$0.70$23,910.60View SEC Filing  
11/11/2015Larry N FeinbergMajor ShareholderBuy54,800$0.79$43,292.00View SEC Filing  
11/10/2015Paul N ClarkDirectorBuy134,579$0.75$100,934.25View SEC Filing  
9/24/2015David C DreyerCFOBuy5,000$1.20$6,000.00View SEC Filing  
9/22/2015David C DreyerCFOBuy5,000$1.37$6,850.00View SEC Filing  
9/17/2015David C DreyerCFOBuy10,000$1.45$14,500.00View SEC Filing  
11/3/2014Jeffrey M NugentCEOBuy40,465$2.39$96,711.35View SEC Filing  
11/3/2014Jonathan T Md LordDirectorBuy101,163$2.39$241,779.57View SEC Filing  
11/3/2014Larry N FeinbergMajor ShareholderBuy2,067,979$2.39$4,942,469.81View SEC Filing  
7/22/2014Alexander K ArrowCOOBuy7,812$1.92$14,999.04View SEC Filing  
7/22/2014Frederick D FurryCFOBuy13,020$1.92$24,998.40View SEC Filing  
7/22/2014Jeffrey M NugentCEOBuy52,083$1.92$99,999.36View SEC Filing  
7/22/2014Paul N ClarkDirectorBuy520,833$1.92$999,999.36View SEC Filing  
7/18/2014Larry N FeinbergMajor ShareholderBuy2,270,836$1.92$4,360,005.12View SEC Filing  
2/12/2014Larry N FeinbergMajor ShareholderBuy2,035,033$2.57$5,230,034.81View SEC Filing  
1/31/2014Larry Feinbergmajor shareholderBuy30,798$2.45$75,455.10View SEC Filing  
12/19/2013Larry Feinbergmajor shareholderBuy340,000$1.80$612,000.00View SEC Filing  
12/17/2013Larry Feinbergmajor shareholderBuy150,400$1.87$281,248.00View SEC Filing  
8/23/2012Frederick D FurryCFOBuy5,075$1.64$8,323.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Biolase (NASDAQ:BIOL)
DateHeadline logoETF’s with exposure to BIOLASE, Inc. : August 29, 2016 (NASDAQ:BIOL) - August 29 at 4:27 PM
News IconNow Available – Worldwide Directed Energy-Based Surgical Systems Market Report 2015-2025 (NASDAQ:BIOL) - August 26 at 11:55 AM
News IconDirected Energy-Based Surgical Systems Market Segments and Key Trends 2015-2025 (NASDAQ:BIOL) - August 17 at 9:18 PM logoDental Equipment Market Sale Value US$5.5 Bn at 2011,Estimated to Reach US$7.6 Bn by 2018 - Research Proved (NASDAQ:BIOL) - August 16 at 3:57 PM logoDental Equipment Market by Product & End User - Global Forecast to 2021 (NASDAQ:BIOL) - August 16 at 3:57 PM
News IconStock Update on BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) - August 11 at 3:53 PM logoPalamina Announces Closing of Oversubscribed $1.2M Private Placement (NASDAQ:BIOL) - August 8 at 9:16 PM logoBIOLASE, INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rights of Security (NASDAQ:BIOL) - August 8 at 9:16 PM logoBIOLASE, INC Financials (NASDAQ:BIOL) - August 6 at 4:16 PM logoForm 4 BIOLASE, INC For: Aug 01 Filed by: CLARK PAUL N - (NASDAQ:BIOL) - August 4 at 9:36 PM logoBIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat (NASDAQ:BIOL) - August 2 at 3:53 PM logoDental Surgical Instrument Research Industry Trends, Growth – Forecast to 2027 (NASDAQ:BIOL) - August 2 at 8:38 AM logoBIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:BIOL) - August 1 at 3:49 PM logoQ2 2016 BIOLASE Inc Earnings Release - After Market Close (NASDAQ:BIOL) - August 1 at 7:07 AM logoBIOLASE Reports 2016 Second Quarter and Six-Month Results (NASDAQ:BIOL) - August 1 at 6:41 AM logoBIOLASE to Raise $10 Million from Institutional and Individual Investors in Convertible Preferred Private Placement (NASDAQ:BIOL) - August 1 at 6:21 AM logoBiolase reports 2Q loss (NASDAQ:BIOL) - August 1 at 6:20 AM
News IconNew report: Dental equipment market is projected to reach 7.52 billion USD by 2021 (NASDAQ:BIOL) - July 25 at 4:21 PM logoBIOLASE : reg; to Host 2016 Second Quarter Financial Results Conference Call on August 1 (NASDAQ:BIOL) - July 25 at 8:38 AM logoBIOLASE® to Host 2016 Second Quarter Financial Results Conference Call on August 1 (NASDAQ:BIOL) - July 25 at 6:28 AM
News IconGlaukos CFO to Retire in 2017 (NASDAQ:BIOL) - July 24 at 8:33 AM
News IconStock Up Nicely This Week: BIOLASE, Inc. (NASDAQ:BIOL) - TGP (NASDAQ:BIOL) - July 23 at 3:47 PM logoAlphatec Holdings Inc versus BIOLASE Inc Head to Head Compare - CML News (NASDAQ:BIOL) - July 22 at 3:49 PM
News IconInsiders Increasing Positions in: BIOLASE, Inc. (NASDAQ:BIOL) - Press Telegraph (NASDAQ:BIOL) - July 21 at 3:53 PM logoBIOLASE Inc versus Cutera Inc Head to Head Compare - CML News (NASDAQ:BIOL) - July 21 at 3:53 PM
News IconStock Moving Lower for the Month; Investor Update on BIOLASE, Inc. (NASDAQ:BIOL) - Engelwood Daily (NASDAQ:BIOL) - July 20 at 11:53 AM logoDental Equipment Market Worth 7.52 Billion USD by 2021 (NASDAQ:BIOL) - July 19 at 10:01 AM logoBIOLASE Inc versus SeaSpine Holdings Corporation Head to Head Compare - CML News (NASDAQ:BIOL) - July 18 at 3:54 PM logoDental Surgical Equipment Market Rising Due to Increasing Prevalence of Dental Diseases and Growing Aging Population (NASDAQ:BIOL) - July 18 at 8:47 AM
News IconShares Moving Down on the Week: BIOLASE, Inc. (NASDAQ:BIOL) - Engelwood Daily (NASDAQ:BIOL) - July 17 at 8:32 AM
News IconShares Experiencing a Downtrend: BIOLASE, Inc. (NASDAQ:BIOL) - TGP (NASDAQ:BIOL) - July 16 at 9:25 AM logoBIOLASE Inc Stock Momentum Hits Weakness - CML News (NASDAQ:BIOL) - July 13 at 9:18 PM logoBiolase, Inc. (BIOL) Updated Price Targets - FTSE News (NASDAQ:BIOL) - July 13 at 3:52 PM logoBIOLASE, Inc. versus Cogentix Medical, Inc. Head to Head Compare - CML News (NASDAQ:BIOL) - July 11 at 3:49 PM
News IconGlobal Refractive Surgery Devices Market 2016- Alcon, Inc., Avedro, Inc., Belkin Laser Ltd, Biolase, Inc., CV Laser ... - cHollywood News Portal (press release) (NASDAQ:BIOL) - July 8 at 3:51 PM logoBroker Outlook For Biolase, Inc. (BIOL) - Fiscal Standard (NASDAQ:BIOL) - July 7 at 11:46 AM
News IconCompany Stock Lower on the Week BIOLASE, Inc. (NASDAQ:BIOL) - Engelwood Daily (NASDAQ:BIOL) - July 2 at 11:29 AM
News IconStock Lower in Session: BIOLASE, Inc. (NASDAQ:BIOL) - Telanagana Press (NASDAQ:BIOL) - July 1 at 3:51 PM
News IconGlobal Dental Surgical Market Development, Regional Analysis, Share and Forecast to 2027. (NASDAQ:BIOL) - June 29 at 3:50 PM logoGlobal Dental Equipment Market to reach USD 1.8 Billion by 2020 (NASDAQ:BIOL) - June 29 at 12:07 PM
News IconUpcoming Opportunities in Asian Dental Lasers Market by Regions like China, India, Japan, South Korea Analysis and ... - (blog) (NASDAQ:BIOL) - June 28 at 4:01 PM logoBiolase, Inc. (BIOL) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:BIOL) - June 27 at 3:29 PM
News IconUpcoming Opportunities in Asian Dental Lasers Market by Regions like China, India, Japan, South Korea Analysis and Forecast to 2019 (NASDAQ:BIOL) - June 27 at 8:31 AM
News IconBiolase Technology Incorporated (NASDAQ:BIOL) Sellers Covered 0.51% of Their Shorts - Engelwood Daily (NASDAQ:BIOL) - June 26 at 9:03 AM logoETF’s with exposure to BIOLASE, Inc. : June 23, 2016 (NASDAQ:BIOL) - June 23 at 1:33 PM logoNew Broker Ratings For Biolase, Inc. (BIOL) - FTSE News (NASDAQ:BIOL) - June 22 at 3:49 PM
News IconGlobal dental lasers market by product, by end user - analysis and forecast to 2019 illuminated by new report (NASDAQ:BIOL) - June 22 at 8:36 AM
News IconDental Lasers North American Market – Opportunities and Forecasts, 2014 – 2022 - (blog) (NASDAQ:BIOL) - June 21 at 3:46 PM logoRecently Issued Stock Ratings For Biolase, Inc. (BIOL) - Fiscal Standard (NASDAQ:BIOL) - June 21 at 8:35 AM logoThis Weeks Broker Views For Biolase, Inc. (BIOL) - Fiscal Standard (NASDAQ:BIOL) - June 20 at 10:15 AM


Biolase (NASDAQ:BIOL) Chart for Tuesday, August, 30, 2016

Last Updated on 8/30/2016 by Staff